ACCEL Lite: Cardiovascular Safety of Testosterone-Replacement Therapy

Testosterone is widely prescribed to aging men but there have been concerns about heart-related safety.  The FDA mandated that the makers of testosterone products conduct a trial to determine if these drugs increase the risk of heart attack or stroke.    In this interview, Steven E. Nissen, MD, MACC, and William E. Boden MD, FACC, discuss Cardiovascular Safety of Testosterone-Replacement Therapy.    Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL    

Om Podcasten

The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.